BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 18666031)

  • 1. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza control in the 21st century: Optimizing protection of older adults.
    Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
    Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of vaccines against influenza A virus (H5N1).
    Li WC; Huang YC
    Chang Gung Med J; 2007; 30(4):294-304. PubMed ID: 17939259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing vaccines against pandemic influenza.
    Wood JM
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential advantages of DNA immunization for influenza epidemic and pandemic planning.
    Webster RG
    Clin Infect Dis; 1999 Feb; 28(2):225-9. PubMed ID: 10064231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influenza vaccination and technologies.
    Nafziger AN; Pratt DS
    J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.